Latest clinical updates | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Clinical

Donanemab provides greater brain amyloid clearance than aducanumab in early Alzheimer’s

Donanemab provides greater brain amyloid clearance than aducanumab in early Alzheimer’s

Enlarged perivascular spaces revealed by MRI in migraine sufferers

Enlarged perivascular spaces revealed by MRI in migraine sufferers

MRI study suggest NSAIDs may worsen arthritis inflammation

MRI study suggest NSAIDs may worsen arthritis inflammation

Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond three years

Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond three years

Deferiprone treatment worsens Parkinson’s disease progression

Deferiprone treatment worsens Parkinson’s disease progression

Higher acetylcholinesterase activity associated with delirium during critical illness

Higher acetylcholinesterase activity associated with delirium during critical illness

No clear temperature threshold for infection screening in hypothermic infants

No clear temperature threshold for infection screening in hypothermic infants

Nirmatrelvir and ritonavir safe in pregnancy

Nirmatrelvir and ritonavir safe in pregnancy

Amino acids supplement improves muscle and gut function in critically ill patients

Amino acids supplement improves muscle and gut function in critically ill patients

Higher mean arterial pressure unlikely to prevent AKI in shock and perioperative patients

Higher mean arterial pressure unlikely to prevent AKI in shock and perioperative patients

Morning physical activity linked to lowest risk of cardiovascular disease

Morning physical activity linked to lowest risk of cardiovascular disease

Early Alzheimer’s disease cognitive decline slowed by lecanemab

Early Alzheimer’s disease cognitive decline slowed by lecanemab

GSK3036656 shows bactericidal activity after 14 days in pulmonary tuberculosis

GSK3036656 shows bactericidal activity after 14 days in pulmonary tuberculosis

Subcutaneous foslevodopa foscarbidopa infusion improves control in Parkinson’s disease

Subcutaneous foslevodopa foscarbidopa infusion improves control in Parkinson’s disease

Statin induced muscle symptoms not improved with vitamin D

Statin induced muscle symptoms not improved with vitamin D

Sutimlimab approved in Europe for cold agglutinin haemolytic anaemia

Sutimlimab approved in Europe for cold agglutinin haemolytic anaemia

Longer rivaroxaban course reduces risk of recurrent venous thromboembolism

Longer rivaroxaban course reduces risk of recurrent venous thromboembolism

Myocarditis rate higher in younger people following mRNA vaccination

Myocarditis rate higher in younger people following mRNA vaccination

x